Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by newdaydawningon Jun 22, 2019 6:07pm
49 Views
Post# 29852982

RE:RE:Oats, we missed the boat on cannabis extracts

RE:RE:Oats, we missed the boat on cannabis extractsBest short-term outcome for CZO is if RTI submits a share exchange merger offer @ $0.60/sh equivalent. My hunch is that most shareholders would accept such an offer. The combined entity would be a powerhouse in cannabinoid extraction.

oats wrote: newday,

I guess you should have bought Radient if you wanted to get into Cannabis, right?

Anyone who cares knew long ago that Ceapro had no interest in this sector and would only enter the medical MJ when the time was right.  Your statements reflect someone who is only concerned about a move in a share price.  You could have accomplished this with 40 different microcap stocks.  If you are not interested in watching or participating in a company being built on a brick by brick basis, why not bail?


Bullboard Posts